[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Critique
May 2011May 16, 2011

Rectal Cancer: The Good, the Bad, and the UglyComment on “Determining the Need for Radical Surgery in Patients with T1 Rectal Cancer ”

Author Affiliations

Author Affiliation: Department of Surgery, Rhode Island Hospital[[ndash]]Brown University, Providence, Rhode Island.

Arch Surg. 2011;146(5):544. doi:10.1001/archsurg.2011.71

The many effective therapeutic options available in the management of rectal cancer have led to greater effort toward pretreatment staging, risk stratification, and individualized treatment. More vigorous treatments carry potentially increased morbidity, longer disability, higher costs, and lasting changes in quality of life. Multimodality therapy is commonly used for “bad” (locally advanced) or “ugly” (metastatic) rectal cancers, but which ones are “good” (early) enough to be curable by local excision? This question is addressed by Dr Salinas and his colleagues.

First Page Preview View Large
First page PDF preview
First page PDF preview
×